- Home
- ENVB vs TCRT Comparison
ENVB vs TCRT Comparison
Compare ENVB & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- TCRT
- Stock Information
- Founded
- ENVB 1994
- TCRT 1998
- Country
- ENVB United States
- TCRT United States
- Employees
- ENVB N/A
- TCRT N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- ENVB Health Care
- TCRT Health Care
- Exchange
- ENVB Nasdaq
- TCRT Nasdaq
- Market Cap
- ENVB 4.2M
- TCRT 3.8M
- IPO Year
- ENVB N/A
- TCRT N/A
- Fundamental
- Price
- ENVB $0.33
- TCRT $2.00
- Analyst Decision
- ENVB Strong Buy
- TCRT
- Analyst Count
- ENVB 1
- TCRT 0
- Target Price
- ENVB $10.00
- TCRT N/A
- AVG Volume (30 Days)
- ENVB 156.7K
- TCRT 33.0K
- Earning Date
- ENVB 11-14-2024
- TCRT 11-14-2024
- Dividend Yield
- ENVB N/A
- TCRT N/A
- EPS Growth
- ENVB N/A
- TCRT N/A
- EPS
- ENVB N/A
- TCRT N/A
- Revenue
- ENVB N/A
- TCRT $7,000.00
- Revenue This Year
- ENVB N/A
- TCRT N/A
- Revenue Next Year
- ENVB N/A
- TCRT N/A
- P/E Ratio
- ENVB N/A
- TCRT N/A
- Revenue Growth
- ENVB N/A
- TCRT N/A
- 52 Week Low
- ENVB $0.30
- TCRT $1.63
- 52 Week High
- ENVB $2.92
- TCRT $33.00
- Technical
- Relative Strength Index (RSI)
- ENVB 40.19
- TCRT 43.99
- Support Level
- ENVB $0.34
- TCRT $1.63
- Resistance Level
- ENVB $0.37
- TCRT $2.10
- Average True Range (ATR)
- ENVB 0.03
- TCRT 0.30
- MACD
- ENVB 0.01
- TCRT -0.04
- Stochastic Oscillator
- ENVB 53.66
- TCRT 21.03
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.